Brian T. Kelly, MD, MA, FACAAI, Midwest Allergy and Asthma Clinic, and the American College of Allergy, Asthma & Immunology annual meeting program chair, discusses the importance of distinguishing between non–immunoglobulin E (IgE)– and IgE-mediated food allergies, as well as remaining up to date on guidance for eosinophilic esophagitis (EoE).
It’s important to promote awareness around these things we don’t necessarily receive formal training on, as well as to help guide our patients who sometimes have difficulty navigating this world of food allergies, stressed Brian T. Kelly, MD, MA, FACAAI, Midwest Allergy and Asthma Clinic, and the American College of Allergy, Asthma & Immunology 2021 Annual Scientific Meeting program chair, who is both moderating and presenting sessions at this year's conference.
Transcript
Is it challenging to get infants and children with suspected EoE and FPIES referred to a specialist for evaluation? If so, what can be done?
I think non-IgE [immunoglobulin E]–mediated food allergies is something that’s not necessarily always at the forefront of some of our referral sources. Some of these things, such as FPIES [food protein–induced enterocolitis syndrome], are rare and not necessarily something that always comes up in pediatric training. Oftentimes, we see these patients out of the emergency room or when they've come from the pediatrician for another concern, such as an IgE-mediated food allergy. I think it is somewhat difficult for patients to navigate that world. One thing that I think the ACAAI and others have done a great job of doing is promoting some of the awareness of these non-IgE–mediated food allergies, because they get somewhat neglected in terms of true IgE-mediated food allergy—and they're quite different—and so we really wanted to highlight that by putting together a session [“Addressing Non-IgE Mediated Food Allergy”] that addresses that specifically with some of the most prominent experts in non-IgE–mediated food allergy.
EoE [eosinophilic esophagitis], in and of itself, is really an area where things have changed throughout the years. Even some of the guidelines have changed and been updated recently. In fact, we talked about the most recent updated guidelines at the 2020 meeting. It's really important for allergists and immunologists to stay up to date on those. We're going to continue to push for that, because we do see those patients a lot in clinic and the recommendations on testing and how to test, and all of those things, have changed. So keeping our members at the forefront of that is going to be important.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More